BIOMAT Database Logo BIOMAT Database Logo

Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. 1993

J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Laboratory for Physiological Chemistry, Utrecht University, The Netherlands.

Type 2 (non-insulin-dependent) diabetes mellitus is characterised by hyperglycaemia, peripheral insulin resistance, impaired insulin secretion and pancreatic islet amyloid formation. The major constituent of islet amyloid is islet amyloid polypeptide (amylin). Islet amyloid polypeptide is synthesized by islet beta cells and co-secreted with insulin. The ability of islet amyloid polypeptide to form amyloid fibrils is related to its species-specific amino acid sequence. Islet amyloid associated with diabetes is only found in man, monkeys, cats and racoons. Pharmacological doses of islet amyloid polypeptide have been shown to inhibit insulin secretion as well as insulin action on peripheral tissues (insulin resistance). To examine the role of islet amyloid polypeptide in the pathogenesis of Type 2 diabetes, we have generated transgenic mice with the gene encoding either human islet amyloid polypeptide (which can form amyloid) or rat islet amyloid polypeptide, under control of an insulin promoter. Transgenic islet amyloid polypeptide mRNA was detected in the pancreas in all transgenic mice. Plasma islet amyloid polypeptide levels were significantly elevated (up to 15-fold) in three out of five transgenic lines, but elevated glucose levels, hyperinsulinaemia and obesity were not observed. This suggests that insulin resistance is not induced by chronic hypersecretion of islet amyloid polypeptide. Islet amyloid polypeptide immunoreactivity was localized to beta-cell secretory granules in all mice. Islet amyloid polypeptide immunoreactivity in beta-cell lysosomes was seen only in mice with the human islet amyloid polypeptide gene, as in human beta cells, and might represent an initial step in intracellular formation of amyloid fibrils.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008297 Male Males
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females

Related Publications

J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation.
June 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Biologically active human islet amyloid polypeptide/amylin in transgenic mice.
January 1997, European journal of endocrinology,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin.
April 1995, European journal of endocrinology,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
[Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
October 1994, Nihon rinsho. Japanese journal of clinical medicine,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Oophorectomy promotes islet amyloid formation in human islet amyloid polypeptide transgenic mice.
February 2001, Diabetes,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice.
December 1998, Brain research. Molecular brain research,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice.
January 2010, Diabetes,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice.
March 2015, Diabetologia,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Postnatally disturbed pancreatic islet cell distribution in human islet amyloid polypeptide transgenic mice.
May 2003, Regulatory peptides,
J W Höppener, and J S Verbeek, and E J de Koning, and C Oosterwijk, and K L van Hulst, and H J Visser-Vernooy, and F M Hofhuis, and S van Gaalen, and M J Berends, and W H Hackeng
Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice.
October 2005, American journal of physiology. Endocrinology and metabolism,
Copied contents to your clipboard!